DrugCite
Search

THYROGEN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Thyrogen Adverse Events Reported to the FDA Over Time

How are Thyrogen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Thyrogen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Thyrogen is flagged as the suspect drug causing the adverse event.

Most Common Thyrogen Adverse Events Reported to the FDA

What are the most common Thyrogen adverse events reported to the FDA?

Nausea
54 (4.99%)
Vomiting
28 (2.59%)
Headache
22 (2.03%)
Dizziness
19 (1.76%)
Asthenia
17 (1.57%)
Fatigue
16 (1.48%)
Malaise
16 (1.48%)
Back Pain
12 (1.11%)
Confusional State
12 (1.11%)
Diarrhoea
12 (1.11%)
Palpitations
12 (1.11%)
Show More Show More
Pain
11 (1.02%)
Myalgia
10 (.92%)
Dehydration
9 (.83%)
Hyperventilation
9 (.83%)
Presyncope
9 (.83%)
Renal Failure
9 (.83%)
Abortion Spontaneous
8 (.74%)
Blood Thyroid Stimulating Hormone I...
8 (.74%)
Chest Pain
8 (.74%)
Cough
8 (.74%)
Hypersensitivity
8 (.74%)
Hypotension
8 (.74%)
Pyrexia
8 (.74%)
Tachycardia
8 (.74%)
Tremor
8 (.74%)
Anxiety
7 (.65%)
Dyspnoea
7 (.65%)
Hypocapnia
7 (.65%)
Hypoxia
7 (.65%)
Muscle Spasms
7 (.65%)
Muscular Weakness
7 (.65%)
Nephrotic Syndrome
7 (.65%)
Rales
7 (.65%)
Abdominal Pain
6 (.55%)
Amnesia
6 (.55%)
Arthralgia
6 (.55%)
Cerebrovascular Accident
6 (.55%)
Hypertension
6 (.55%)
Loss Of Consciousness
6 (.55%)
Nephrolithiasis
6 (.55%)
Renal Colic
6 (.55%)
Syncope
6 (.55%)
Vertigo
6 (.55%)
Dyspnoea Exertional
5 (.46%)
Hyperthyroidism
5 (.46%)
Hypoaesthesia
5 (.46%)
Incorrect Route Of Drug Administrat...
5 (.46%)
Lymphadenopathy
5 (.46%)
Pain In Extremity
5 (.46%)
Paraesthesia
5 (.46%)
Ventricular Hypertrophy
5 (.46%)
Vision Blurred
5 (.46%)
Weight Increased
5 (.46%)
Acute Myocardial Infarction
4 (.37%)
Balance Disorder
4 (.37%)
Blood Pressure Increased
4 (.37%)
Blood Pressure Systolic Decreased
4 (.37%)
Bronchospasm
4 (.37%)
Cerebellar Infarction
4 (.37%)
Condition Aggravated
4 (.37%)
Deep Vein Thrombosis
4 (.37%)
Depression
4 (.37%)
Hiatus Hernia
4 (.37%)
Hyperhidrosis
4 (.37%)
Influenza Like Illness
4 (.37%)
Insomnia
4 (.37%)
Lacunar Infarction
4 (.37%)
Mitral Valve Incompetence
4 (.37%)
Neutropenia
4 (.37%)
Paraesthesia Oral
4 (.37%)
Red Blood Cell Sedimentation Rate I...
4 (.37%)
Respiratory Disorder
4 (.37%)
Sinusitis
4 (.37%)
Thalamic Infarction
4 (.37%)
Thrombophlebitis
4 (.37%)
White Blood Cell Count Decreased
4 (.37%)
Aptyalism
3 (.28%)
Arthritis
3 (.28%)
Atrial Fibrillation
3 (.28%)
Blood Calcium Decreased
3 (.28%)
Blood Homocysteine Increased
3 (.28%)
Chest X-ray Abnormal
3 (.28%)
Chronic Obstructive Pulmonary Disea...
3 (.28%)
Cognitive Disorder
3 (.28%)
Dacryostenosis Acquired
3 (.28%)
Disturbance In Attention
3 (.28%)
Diverticulitis
3 (.28%)
Dry Mouth
3 (.28%)
Ecchymosis
3 (.28%)
Epistaxis
3 (.28%)
Erythema
3 (.28%)
Fall
3 (.28%)
Fear
3 (.28%)
Feeling Hot
3 (.28%)
Gastroenteritis
3 (.28%)
Heart Rate Decreased
3 (.28%)
Hyperkalaemia
3 (.28%)
International Normalised Ratio Incr...
3 (.28%)
Joint Swelling
3 (.28%)
Lipase Increased
3 (.28%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Thyrogen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Thyrogen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Thyrogen

What are the most common Thyrogen adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Thyrogen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Thyrogen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Thyrogen According to Those Reporting Adverse Events

Why are people taking Thyrogen, according to those reporting adverse events to the FDA?

Diagnostic Procedure
121
Drug Use For Unknown Indication
19
Therapeutic Procedure
19
Product Used For Unknown Indication
14
Goitre
14
Thyroid Cancer
11
Show More Show More
Scan Thyroid Gland
8
Metastasis
6
Investigation
2
Toxic Nodular Goitre
2
Whole Body Scan
2
Radioactive Iodine Therapy
2
Thyroid Operation
1
Thyroidectomy
1
Premedication
1
Hyperthyroidism
1
High Frequency Ablation
1
Postoperative Care
1

Drug Labels

LabelLabelerEffective
ThyrogenGenzyme Corporation01-JUL-12

Thyrogen Case Reports

What Thyrogen safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Thyrogen. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Thyrogen.